Provided by Tiger Fintech (Singapore) Pte. Ltd.

TELA Bio, Inc.

1.89
-0.0600-3.08%
Post-market: 1.890.00000.00%16:18 EDT
Volume:117.30K
Turnover:221.82K
Market Cap:74.76M
PE:-1.46
High:1.99
Open:1.99
Low:1.82
Close:1.95
Loading ...

Dow Tumbles Over 400 Points; Nike Shares Dip After Q3 Results

Benzinga
·
21 Mar

Wall Street Set to Open Lower Friday as Investors Look to End Losing Week Streak

MT Newswires Live
·
21 Mar

Tela Bio price target lowered to $6 from $8 at Lake Street, buy on weakness

TIPRANKS
·
21 Mar

Investors Face Another Losing Week as US Futures Lower Slip Pre-Bell

MT Newswires Live
·
21 Mar

Top Premarket Decliners

MT Newswires Live
·
21 Mar

Piper Sandler Downgrades TELA Bio to Neutral From Overweight, Adjusts Price Target to $2 From $5

MT Newswires Live
·
21 Mar

TELA Bio Cut to Neutral From Overweight by Piper Sandler

Dow Jones
·
21 Mar

TELA Bio’s Hold Rating: Challenges in Sales Force Turnover and Financial Outlook

TIPRANKS
·
21 Mar

TELA Bio, Inc. (TELA) Reports Q4 Loss, Misses Revenue Estimates

Zacks
·
21 Mar

TELA Bio Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
21 Mar

TELA Bio Q4 Net Loss Narrows, Revenue Rises; 2025 Sales Outlook Set -- Shares Fall After Hours

MT Newswires Live
·
21 Mar

TELA Bio Q4 2024 GAAP EPS $(0.23) Misses $(0.22) Estimate, Sales $17.649M Miss $23.166M Estimate

Benzinga
·
21 Mar

BRIEF-TELA Bio Q4 Revenue USD 17.649 Million Vs. IBES Estimate USD 23.2 Million

Reuters
·
21 Mar

TELA Bio Q4 Basic EPS USD -0.23

THOMSON REUTERS
·
21 Mar

TELA Bio Inc Outlook Q1 REV $17.0 Million to $18.0 Million

THOMSON REUTERS
·
21 Mar

TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
·
21 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
20 Mar

TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
·
28 Feb

BRIEF-Tela Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
22 Feb

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
22 Feb